Showing results (441-450 of 520) with videos related to
Sort By:
Pageof 52
Cardiovascular & Hematological Agents in Medicinal Chemistry|November 1, 2006
Selective serotonin re-uptake inhibitors for the treatment of depression in coronary artery disease and chronic heart failure: evidence for pleiotropic effectsIoannis Paraskevaidis, John T Parissis, Katerina Fountoulaki, et al.Cardiovascular & Hematological Agents in Medicinal Chemistry|November 1, 2006
A new approach for treatment of hypertension: modifying D1 dopamine receptor functionChunyu Zeng, Robin A Felder, Pedro A JoseCardiovascular & Hematological Agents in Medicinal Chemistry|December 3, 2013
Serelaxin: new investigational treatment in acute heart failureSarmad Said, Debabrata MukherjeeCardiovascular & Hematological Agents in Medicinal Chemistry|November 10, 2015
A Review of Sodium Glucose Co-transporter 2 Inhibitors Canagliflozin, Dapagliflozin and EmpagliflozinSaad Hussain Syed, Sucheta Gosavi, Waseem Shami, et al.Cardiovascular & Hematological Agents in Medicinal Chemistry|June 23, 2009
Female sexual dysfunction: therapeutic options and experimental challengesKyan J Allahdadi, Rita C A Tostes, R Clinton WebbCardiovascular & Hematological Agents in Medicinal Chemistry|August 20, 2009
Anticoagulation in patients with heart failureR Sacha Bhatia, Maral Ouzounian, Jack V Tu, et al.Cardiovascular & Hematological Agents in Medicinal Chemistry|August 20, 2009
Optimal management of hypertension in patients with ischemic heart diseaseDebabrata Mukherjee, Charles L CampbellCardiovascular & Hematological Agents in Medicinal Chemistry|July 18, 2009
Palifermin in the management of mucositis in hematological malignancies: current evidences and future perspectivesPasquale Niscola, Laura Scaramucci, Marco Giovannini, et al.Cardiovascular & Hematological Agents in Medicinal Chemistry|July 18, 2009
Current status of rho-associated kinases (ROCKs) in coronary atherosclerosis and vasospasmMing Dong, Bryan P Yan, Chuek-Man YuCardiovascular & Hematological Agents in Medicinal Chemistry|September 10, 2011
Optimal medical therapy for coronary artery disease in 2011 - perspectives from the STICH TrialThomas F Whayne, Sibu P Saha, Karla Quevedo, et al.Pageof 52